UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 17, 2016
Accession Number:
0001193125-16-593189
Submission Type:
POS AM
CIK:
0001503802
Company Name:
Karyopharm Therapeutics Inc.
File Number:
333-201366